Professional Documents
Culture Documents
In 1880, Burroughs Wellcome & Company was founded in London by American pharmacists Henry Wellcome and Silas Burroughs. Glaxo was founded in Bunnythorpe, New Zealand in 1904. Originally Glaxo was a baby food manufacturer processing local milk into a baby food by the same name: the product was sold in the 1930s under the slogan "glaxo builds bonny babies". In 1830, John K. Smith opened its first pharmacy in Philadelphia. In 1865 mahlonKline joined the business which, 10 years later, became Smith, Kline & Co. In 2000, glaxo welcome and SmithKline Beecham merged to form GlaxoSmithKline.
GSK IN PAKISTAN
GlaxoSmithKline Pakistan Limited was created on January 1st 2002 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan (Private) Limited and Glaxo Wellcome (Pakistan) Limited- standing today as the largest pharmaceutical company in Pakistan. and
GSK Pakistan operates mainly in two industry segments: Pharmaceuticals (prescription drugs and vaccines) and consumer healthcare (over-the-counter- medicines, oral care and nutritional care).
GSK INTERNAL VIEW GSK BALANCE SHEET VIEW FOR FIRST QUARTER OF 2010:
Total Current Assets Total Total Total Total Total Fixed Assets Assets Liabilities Equity Liabilities & Stock Equity 25,106,856 29,583,065 66,117,643 52,203,660 13,913,982 66,117,643
PANADOL EXTRA
AUGMINTEN
MACLEANS SENSITIVE
HORLICKS
Abbott Laboratories has its origin in the late 19th century in a small
pharmaceutical operation run from the kitchen of a Chicago physician named Wallace Calvin Abbott. As did other physicians of the time, Dr. Abbott commonly prescribed morphine, quinine, strychnine, and codeine--all of which were liquid alkaloid extracts--for his patients. Because they existed only in a liquid form, these drugs were prone to spoilage over timemitigating their effectiveness
as
treatment.
Mission
To deliver consistently superior products and services which contribute significantly to improvethe quality of life of the consumers.
ABBOTT
PAKISTAN
INTERNAL
VIEW
Market Share
Abbott Pakistan achieved a market share of 6.1% as per IMS (Dec 2010, 12 Months) in the pharmaceutical and nutrition market (2009 market share: 5.8%).
ABBOTT LABORTRIES OF PAKISTAN`s MAIN PRODUCT Abbott Labortries of Pakistan engaged in the following product catagery. ABBOTT DIABATIES PRODUCT
Pharmaceutical Products
brufen sirup
Nutritional Products
NUTRITIONAL PRODUCTS
Internal
Strengths
Weaknesses
Continued uptake of Humira across autoimmune disorder market Diverse lipid management portfolio Blockbuster HIV franchise
Patent exposure set to weaken prescription pharma portfolio Narrow launch prospects largely restricted to follow-on medications
External
Opportunities
Threats
Exciting prospect for lucrative vascular intervention segment in Xience V Early stage pipeline programs in oncology, CNS and immunology
FTC investigation into generic defence strategies New biologic launches for autoimmune disorder market